Evidence map›Paper›PMID 31821786›Full record

ArticleCancer cell2019

Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven Lung Adenocarcinoma.

Ning Yin, Yi Liu, Andras Khoor, Xue Wang, E Aubrey Thompson, Michael Leitges, Verline Justilien, Capella Weems, Nicole R Murray, Alan P Fields

Abstract readPublished Erratum
In one paragraph

Article in Cancer cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Ning Yin
Yi Liu
Andras Khoor
Xue Wang
E Aubrey Thompson
Michael Leitges
Verline Justilien
Capella Weems
Nicole R Murray
Alan P Fields

Funding

Three-Dimensional Organoid Cultures to Investigate 3q26 Driver Functions in Multiple Lung Cancer Cells of OriginR01CA081436 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI FIELDS, ALAN P. · 1999 to 2022
$9.9M
Therapeutic targeting of Kras-driven Lung AdenocarcinomaR01CA206367 · NCI · MAYO CLINIC JACKSONVILLE · PI FIELDS, ALAN P. · 2016 to 2020
$1.8M
NCI NIH HHS R01 CA081436NCI NIH HHS R01 CA206367
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31821786
PMCPMC6993938

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.